Literature DB >> 14998318

Selective optimization of side activities: another way for drug discovery.

Camille G Wermuth1.   

Abstract

Mesh：

Substances：

Year:  2004        PMID： 14998318     DOI： 10.1021/jm030480f

Source DB:  PubMed          Journal:  J Med Chem        ISSN： 0022-2623            Impact factor:   7.446


× No keyword cloud information.
  34 in total

1.  Chemogenomic approaches to drug discovery: similar receptors bind similar ligands.

Authors:  T Klabunde
Journal:  Br J Pharmacol       Date:  2007-05-29       Impact factor: 8.739

Review 2.  High-content drug screening with engineered musculoskeletal tissues.

Authors:  Herman Vandenburgh
Journal:  Tissue Eng Part B Rev       Date:  2010-02       Impact factor: 6.389

Review 3.  K+ channel modulators for the treatment of neurological disorders and autoimmune diseases.

Authors:  Heike Wulff; Boris S Zhorov
Journal:  Chem Rev       Date:  2008-05       Impact factor: 60.622

4.  The University of Kansas High-Throughput Screening Laboratory. Part II: enabling collaborative drug-discovery partnerships through cutting-edge screening technology.

Authors:  Peter R McDonald; Anuradha Roy; Rathnam Chaguturu
Journal:  Future Med Chem       Date:  2011-07       Impact factor: 3.808

5.  6-Substituted Hexamethylene Amiloride (HMA) Derivatives as Potent and Selective Inhibitors of the Human Urokinase Plasminogen Activator for Use in Cancer.

Authors:  Benjamin J Buckley; Ashraf Aboelela; Elahe Minaei; Longguang X Jiang; Zhihong Xu; Umar Ali; Karen Fildes; Chen-Yi Cheung; Simon M Cook; Darren C Johnson; Daniel A Bachovchin; Gregory M Cook; Minoti Apte; Mingdong Huang; Marie Ranson; Michael J Kelso
Journal:  J Med Chem       Date:  2018-09-07       Impact factor: 7.446

Review 6.  High-content drug screening for rare diseases.

Authors:  F Bellomo; D L Medina; E De Leo; A Panarella; F Emma
Journal:  J Inherit Metab Dis       Date:  2017-06-07       Impact factor: 4.982

Review 7.  Molecular networks in drug discovery.

Authors:  John Kenneth Morrow; Longzhang Tian; Shuxing Zhang
Journal:  Crit Rev Biomed Eng       Date:  2010

Review 8.  Connexin channel modulators and their mechanisms of action.

Authors:  Vytas K Verselis; Miduturu Srinivas
Journal:  Neuropharmacology       Date:  2013-04-15       Impact factor: 5.250

9.  Perhexiline maleate enhances antitumor efficacy of cisplatin in neuroblastoma by inducing over-expression of NDM29 ncRNA.

Authors:  Serena Vella; Ilaria Penna; Luca Longo; Giulia Pioggia; Patrizia Garbati; Tullio Florio; Fabio Rossi; Aldo Pagano
Journal:  Sci Rep       Date:  2015-12-17       Impact factor: 4.379

10.  6-Substituted amiloride derivatives as inhibitors of the urokinase-type plasminogen activator for use in metastatic disease.

Authors:  Benjamin J Buckley; Hiwa Majed; Ashraf Aboelela; Elahe Minaei; Longguang Jiang; Karen Fildes; Chen-Yi Cheung; Darren Johnson; Daniel Bachovchin; Gregory M Cook; Mingdong Huang; Marie Ranson; Michael J Kelso
Journal:  Bioorg Med Chem Lett       Date:  2019-10-28       Impact factor: 2.823
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.